US 6653323
Aryl aniline &bgr;2 adrenergic receptor agonists
expired A61PA61P43/00
Quick answer
US patent 6653323 (Aryl aniline &bgr;2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P43/00